Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Start Over |
Back to Previous Screen
Erythrocin Lactobionate Lyophilized Powder for Injection
Status: Currently in Shortage
» Date first reported:
» Therapeutic Categories: Anti-Infective; Pediatric
Company Contact Information
||Availability and Estimated Shortage Duration
||Shortage Reason (per FDASIA)
|500 mg Add-Vantage Vial (NDC 0409-6476-44)
Next delivery October 2014; Estimated recovery 1Q 2015.
||Please check with your wholesaler for available inventory. Shortage per Manufacturer: Manufacturing delay.
|500 mg Vial (NDC 0409-6482-01)
||Please check with your wholesaler for available inventory. Shortage per Manufacturer: Available.